CanAG Diagnostics launches free-Prostate Specific Antigen (PSA) test:
This article was originally published in Clinica
Executive Summary
CanAg Diagnostics (Sweden) has launched a free-PSA test. Intended for use with total PSA determinations in prostate cancer management, the test comes in a 96-well format, has an incubation time of two hours and is sensitive to 0.05 micro g/L in a 50 micro l sample. Wallac (Finland) launched a free and total PSA kit for its manual and automated Delphia systems earlier this year (see Clinica No 650/51, p 23).
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.